Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-09-05

Clinical Trial Update: Hydromorphone Hydrochloride Epidural Preemptive Analgesia for Postoperative Pain After Cesarean Section [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating hydromorphone hydrochloride given epidurally as preemptive analgesia for postoperative pain after cesarean section has compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Hydromorphone hydrochloride (hydromorphone hydrochloride)

Snippet

Sponsor: Liquan Liang | Conditions: Post-surgical Pain | Phase 4 | Status: COMPLETED